Cite

HARVARD Citation

    Aitken, D. et al. (2018). A randomised double-blind placebo-controlled crossover trial of HUMira (adalimumab) for erosive hand OsteoaRthritis – the HUMOR trial. Osteoarthritis and cartilage. 26 (7), pp. 880-887. [Online]. 
  
Back to record